Effect of the COVID-19 Pandemic on Place of Death Among Medicaid and Commercially Insured Patients With Cancer in Washington State
- 10 March 2023
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (8) , 1610-1617
Abstract
The COVID-19 pandemic–related disruptions in health care delivery might have affected end-of-life care in patients with cancer. We examined changes in place of death and hospice support for Medicaid and commercially insured patients during the pandemic. We linked Washington State cancer registry records with claims from Medicaid and two commercial insurers for patients with solid tumor age 18-64 years. The study included 322 Medicaid and 162 commercial patients who died between March 2017 and June 2019 (pre–COVID-19), along with 90 Medicaid and 47 commercial patients who died between March and June 2020 (COVID-19). Place of death was categorized as hospital, hospice (home or nonhospital facility), and home without hospice. Place of death was compared using adjusted multinomial logistic regressions stratified by payer and time period (pre–COVID-19 v COVID-19). The clinical and sociodemographic factors associated with dying at home without hospice were examined, and adjusted marginal effects (ME) are reported. In the adjusted pre–COVID-19 analysis, Medicaid patients were more likely than commercially insured patients to die in hospital (48% v 36%; adjusted ME, 11%; P = .02). In the pre–COVID-19/COVID-19 analysis, Medicaid patients' place of death shifted from hospital (48% v 32%; ME, −16%; P < .01) to home without hospice (19.9% v 38.0%; ME, 16.5%; P < .01). However, there were no statistically significant changes pre–COVID-19/COVID-19 for commercial patients. As a result, during COVID-19, Medicaid patients were more likely than commercial patients to die at home without hospice (38% v 22%; ME, 16%; P = .04) as were male versus female patients (ME, 16%; P < .01). The pandemic might have disproportionately worsened the end-of-life experience for Medicaid enrollees with cancer. Attention should be paid to societal and health system factors that decrease access to care for Medicaid patients.Keywords
This publication has 31 references indexed in Scilit:
- Variation in Intensity and Costs of Care by Payer and Race for Patients Dying of Cancer in TexasMedical Care, 2015
- Place of Death and the Differences in Patient Quality of Death and Dying and Caregiver BurdenJournal of Clinical Oncology, 2015
- Association Between the Medicare Hospice Benefit and Health Care Utilization and Costs for Patients With Poor-Prognosis CancerJAMA, 2014
- Hospice Admissions for Cancer in the Final Days of Life: Independent Predictors and Implications for Quality MeasuresJournal of Clinical Oncology, 2014
- Underuse of Hospice Care by Medicaid-Insured Patients With Stage IV Lung Cancer in New York and CaliforniaJournal of Clinical Oncology, 2013
- Place of Death: Correlations With Quality of Life of Patients With Cancer and Predictors of Bereaved Caregivers' Mental HealthJournal of Clinical Oncology, 2010
- Increased Satisfaction with Care and Lower Costs: Results of a Randomized Trial of In‐Home Palliative CareJournal of the American Geriatrics Society, 2007
- Family Perspectives on End-of-Life Care at the Last Place of CareJAMA, 2004
- Barriers and Enablers to Hospice Referrals: An Expert OverviewJournal of Palliative Medicine, 2002
- Place of Care in Advanced Cancer: A Qualitative Systematic Literature Review of Patient PreferencesJournal of Palliative Medicine, 2000